PMID- 8900415 OWN - NLM STAT- MEDLINE DCOM- 19961216 LR - 20131121 IS - 0003-9861 (Print) IS - 0003-9861 (Linking) VI - 334 IP - 2 DP - 1996 Oct 15 TI - Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. PG - 389-94 AB - Hypoxia-inducible factor 1 (HIF-1) is a DNA-binding heterodimeric protein complex originally described in the transcriptional activation of the erythropoietin gene by hypoxia. This protein complex is composed of two subunits, HIF-1alpha and -1beta (aryl hydrocarbon receptor nuclear translocator, ARNT). In this study, we used ARNT-deficient cells, derived from the mouse hepatoma cell line Hepa1c1c7, to further characterize HIF-1 complex formation and its relationship with gene activation by hypoxia and desferrioxamine (Df). Gel shift assays revealed that ARNT is absolutely required for the formation of the HIF-1 DNA-binding complex. Results from RNase protection assays and Northern blots showed that the lack of functional HIF-1 complex completely abrogated the response to hypoxia of vascular endothelial growth factor (VEGF) and the glycolytic enzymes aldolase A (ALDA) and phosphoglycerate kinase 1 (PGK-1), genes known to be upregulated by low oxygen tension. Desferrioxamine induction of VEGF and PGK-1 genes was reduced in the ARNT-deficient cells, but at difference with hypoxia, it was not completely suppressed. These results suggest that Df is able to activate gene transcription through HIF-1-independent mechanisms. Exposure to hypoxia or Df did not induce any changes in HIF-1alpha and -1beta mRNA levels, suggesting that posttranscriptional mechanisms are involved in HIF-1 complex activation. FAU - Salceda, S AU - Salceda S AD - Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. FAU - Beck, I AU - Beck I FAU - Caro, J AU - Caro J LA - eng GR - 1 F32 HL 09247/HL/NHLBI NIH HHS/United States GR - DK-34642/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Arch Biochem Biophys JT - Archives of biochemistry and biophysics JID - 0372430 RN - 0 (Actins) RN - 0 (Arnt protein, mouse) RN - 0 (DNA-Binding Proteins) RN - 0 (Endothelial Growth Factors) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Lymphokines) RN - 0 (Nuclear Proteins) RN - 0 (Receptors, Aryl Hydrocarbon) RN - 0 (Transcription Factors) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (Vascular Endothelial Growth Factors) RN - 138391-32-9 (Aryl Hydrocarbon Receptor Nuclear Translocator) RN - EC 2.7.2.3 (Phosphoglycerate Kinase) RN - EC 4.1.2.13 (Fructose-Bisphosphate Aldolase) RN - J06Y7MXW4D (Deferoxamine) SB - IM MH - Actins/biosynthesis MH - Animals MH - Aryl Hydrocarbon Receptor Nuclear Translocator MH - Blotting, Northern MH - Cell Hypoxia MH - Cell Line MH - Cell Nucleus/metabolism MH - DNA-Binding Proteins/*metabolism MH - Deferoxamine/pharmacology MH - Endothelial Growth Factors/biosynthesis MH - Fructose-Bisphosphate Aldolase/biosynthesis MH - *Gene Expression Regulation, Neoplastic/drug effects MH - Hypoxia-Inducible Factor 1 MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Liver Neoplasms, Experimental MH - Lymphokines/biosynthesis MH - Mice MH - Nuclear Proteins/*metabolism MH - Phosphoglycerate Kinase/biosynthesis MH - Receptors, Aryl Hydrocarbon/*biosynthesis MH - Transcription Factors/*metabolism MH - Transcriptional Activation MH - Tumor Cells, Cultured MH - Vascular Endothelial Growth Factor A MH - Vascular Endothelial Growth Factors EDAT- 1996/10/15 00:00 MHDA- 1996/10/15 00:01 CRDT- 1996/10/15 00:00 PHST- 1996/10/15 00:00 [pubmed] PHST- 1996/10/15 00:01 [medline] PHST- 1996/10/15 00:00 [entrez] AID - S0003-9861(96)90469-5 [pii] AID - 10.1006/abbi.1996.0469 [doi] PST - ppublish SO - Arch Biochem Biophys. 1996 Oct 15;334(2):389-94. doi: 10.1006/abbi.1996.0469.